#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Short stature Chondrodystrophy Philadelphia positive acute lymphocytic leukaemia Synovial sarcoma recurrent C3 glomerulopathy Neurodevelopmental disorder Myelodysplastic syndrome with excess blasts Anti-HLA antibody test positive Thrombotic thrombocytopenic purpura Chronic kidney disease Congenital ectodermal dysplasia Glycogen storage disease type II Immune thrombocytopenia Squamous cell carcinoma of the oral cavity Chemical burn More trials…

    Learn about Rare Diseases

    Myelodysplastic syndrome with excess blasts – Trials in Disease Osteosarcoma metastatic – Trials in Disease Fragile X syndrome – Diagnostics Rhabdoid tumour Angiosarcoma metastatic – Trials in Disease Mantle cell lymphoma stage III – Life with Disease Chondrosarcoma metastatic – Trials in Disease Haemophilia A without inhibitors – Diagnostics Hyperoxaluria – Diagnostics Progressive supranuclear palsy More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bi 685509 Posenacaftor Bay 3018250 Atomoxetine Ict01 Sapablursen Aprepitant Linezolid PIROXICAM Masofaniten Niraparib Tosilate Monohydrate Vobramitamab Duocarmazine Gfh925 Eprosartan Mesilate Olopatadine Clazakizumab Metreleptin Florbetapir (18F) GSKVX000000034798 Kyv-101 More therapies…

    Learn about Your Condition

    Atrial septal defect Interstitial lung disease Crigler-Najjar syndrome Hypersomnia End stage renal disease Pneumococcal infection Pancreatitis acute Immunosuppression Organ donor Vascular calcification Mixed dementia Femur fracture Primary amyloidosis Ataxia telangiectasia Systemic sclerosis pulmonary More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study on Improving Small Bowel Visualization in Capsule Endoscopy for Patients Using Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, and Simeticone

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Macrogol 3350
    • Sodium Ascorbate
    • Simeticone
    Spain

  • Study on the Safety and Effectiveness of Nivolumab and Ipilimumab for Patients with Metastatic Colorectal Cancer with dMMR or MSI

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    • Colorectal cancer metastatic
    Investigated Drugs:
    • Ipilimumab
    • Nivolumab
    France

  • Study on Fecal Microbiota Transplantation with Infliximab and Vedolizumab for Patients with Ulcerative Colitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Investigated Drugs:
    • Vedolizumab
    • Infliximab
    Finland

  • Study Comparing Antibiotic Treatment with Placebo for Patients with Acute Appendicitis Using Ertapenem, Metronidazole, and Levofloxacin

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ertapenem
    • Levofloxacin
    • Metronidazole
    Finland

  • Study on the Effectiveness and Safety of Amoxicillin, Clavulanic Acid, and Metronidazole for Treating Acute Appendicitis in Children Aged 7 to 18

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Ampicillin
    • Amoxicillin
    • Ceftazidime Pentahydrate
    Latvia

  • Study on Bupropion Hydrochloride and Naltrexone Hydrochloride for Patients with Weight Regain After Bariatric Surgery

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Metabolic surgery
    • Obesity
    Investigated Drugs:
    • Naltrexone Hydrochloride
    • Bupropion Hydrochloride
    The Netherlands
Previous Page
1 … 51 52 53 54 55 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!